Medy-Tox Inc.

KOSDAQ:A086900 株式レポート

時価総額：₩1.3t

このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Medy-Tox マネジメント

マネジメント 基準チェック /04

現在、CEO に関する十分な情報がありません。

主要情報

Hyun-Ho Jung

最高経営責任者

n/a

報酬総額

CEO給与比率n/a
CEO在任期間no data
CEOの所有権19.7%
経営陣の平均在職期間データなし
取締役会の平均在任期間データなし

経営陣の近況

Recent updates

Medy-Tox Inc. (KOSDAQ:086900) Surges 37% Yet Its Low P/S Is No Reason For Excitement

Jul 19
Medy-Tox Inc. (KOSDAQ:086900) Surges 37% Yet Its Low P/S Is No Reason For Excitement

Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think

Mar 31
Medy-Tox's (KOSDAQ:086900) Anemic Earnings Might Be Worse Than You Think

Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares

Feb 27
Medy-Tox Inc.'s (KOSDAQ:086900) Prospects Need A Boost To Lift Shares

Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield

Apr 02
Tread With Caution Around Medy-Tox Inc.'s (KOSDAQ:086900) 0.4% Dividend Yield

A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns

Feb 09
A Look At Medy-Tox's (KOSDAQ:086900) Share Price Returns

Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend

Dec 18
Read This Before Buying Medy-Tox Inc. (KOSDAQ:086900) For Its Dividend

CEO（最高経営責任者

Hyun-Ho Jung (62 yo)

no data

在職期間

Mr. Hyun-Ho Jung serves as the Chief Executive Officer of Medy-Tox Inc. Mr. Hyun obtained Doctor of Science degree from Korea Advanced Institute of Science and Technology.